Douglas Reding

1.4k total citations
18 papers, 1.0k citations indexed

About

Douglas Reding is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Douglas Reding has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Douglas Reding's work include Ovarian cancer diagnosis and treatment (3 papers), Cancer survivorship and care (3 papers) and Prostate Cancer Treatment and Research (3 papers). Douglas Reding is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Cancer survivorship and care (3 papers) and Prostate Cancer Treatment and Research (3 papers). Douglas Reding collaborates with scholars based in United States and Canada. Douglas Reding's co-authors include Richard B. Hayes, Danette Hann, Maxine M. Denniston, Thomas J. Flynn, Frank Baker, Dean H. Gesme, Regina G. Ziegler, John Kennedy, Amy F. Subar and Christine Cole Johnson and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and American Journal of Epidemiology.

In The Last Decade

Douglas Reding

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Reding United States 13 419 268 166 154 144 18 1.0k
Rosalina Jorge Koifman Brazil 21 707 1.7× 315 1.2× 108 0.7× 87 0.6× 103 0.7× 93 1.6k
Isaac J. Ergas United States 20 788 1.9× 184 0.7× 251 1.5× 155 1.0× 158 1.1× 52 1.4k
Maria Jackson Jamaica 25 182 0.4× 531 2.0× 85 0.5× 170 1.1× 107 0.7× 66 1.4k
Deborah A. Boggs United States 28 560 1.3× 545 2.0× 127 0.8× 419 2.7× 251 1.7× 43 1.9k
C Hermon United Kingdom 20 413 1.0× 344 1.3× 111 0.7× 74 0.5× 72 0.5× 29 1.6k
Noritoshi Tanida Japan 21 329 0.8× 190 0.7× 56 0.3× 93 0.6× 124 0.9× 63 1.4k
Chong Teh United States 17 424 1.0× 387 1.4× 79 0.5× 181 1.2× 329 2.3× 25 1.8k
T. Greg Hislop Canada 14 534 1.3× 496 1.9× 48 0.3× 141 0.9× 132 0.9× 25 1.2k
Sameer M. Siddiqi United States 12 511 1.2× 145 0.5× 260 1.6× 239 1.6× 101 0.7× 34 1.1k
J R Daling United States 17 290 0.7× 250 0.9× 251 1.5× 106 0.7× 78 0.5× 30 1.1k

Countries citing papers authored by Douglas Reding

Since Specialization
Citations

This map shows the geographic impact of Douglas Reding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Reding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Reding more than expected).

Fields of papers citing papers by Douglas Reding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Reding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Reding. The network helps show where Douglas Reding may publish in the future.

Co-authorship network of co-authors of Douglas Reding

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Reding. A scholar is included among the top collaborators of Douglas Reding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Reding. Douglas Reding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Marcus, Pamela M., Saundra S. Buys, Timothy R. Church, et al.. (2015). Building Successful Relationships in the PLCO Cancer Screening Trial. Reviews on Recent Clinical Trials. 10(3). 181–186. 1 indexed citations
2.
Crawford, David, Zaina P. Qureshi, Nicole Mittmann, et al.. (2013). Estimating The Cost For Prostate Cancer (Pca) Screening Using The Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial Data. Value in Health. 16(3). A151–A151. 1 indexed citations
3.
Black, Angela, Charles D. Johnson, Lois Lamerato, et al.. (2011). Effect of screening on ovarian cancer mortality in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer randomized screening trial.. Journal of Clinical Oncology. 29(15_suppl). 5001–5001. 5 indexed citations
4.
Reding, Douglas, Catherine A. McCarty, Tom Riley, Tom Hickey, & William G. Hocking. (2010). Positive biopsy (bx) rates for prostate cancer (PCA) based on prostate specific antigen (PSA) grouping in a large cancer screening trial: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).. Journal of Clinical Oncology. 28(15_suppl). 4563–4563. 8 indexed citations
5.
Reding, Douglas, et al.. (2008). Prevalence, incidence and natural history of simple ovarian cysts within the context of a large cancer screening trial. Journal of Clinical Oncology. 26(15_suppl). 5571–5571. 1 indexed citations
6.
Huang, Wen‐Yi, Richard B. Hayes, Ruth M. Pfeiffer, et al.. (2008). Sexually Transmissible Infections and Prostate Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 17(9). 2374–2381. 64 indexed citations
7.
Daugherty, Sarah E., Yin Yao Shugart, Elizabeth A. Platz, et al.. (2007). Polymorphic variants in α‐methylacyl‐CoA racemase and prostate cancer. The Prostate. 67(14). 1487–1497. 17 indexed citations
8.
Baker, Frank, Maxine M. Denniston, Danette Hann, et al.. (2007). Factor Structure and Concurrent Validity of the Satisfaction with Life Domains Scale for Cancer (SLDS-C). Journal of Psychosocial Oncology. 25(2). 1–17. 14 indexed citations
9.
Lacey, James V., Mark H. Greene, Saundra S. Buys, et al.. (2006). Ovarian Cancer Screening in Women With a Family History of Breast or Ovarian Cancer. Obstetrics and Gynecology. 108(5). 1176–1184. 22 indexed citations
10.
Chang, Shih-Chen, Regina G. Ziegler, Barbara Dunn, et al.. (2006). Association of Energy Intake and Energy Balance with Postmenopausal Breast Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiology Biomarkers & Prevention. 15(2). 334–341. 58 indexed citations
11.
Cross, Amanda J., Ulrike Peters, Victoria A. Kirsh, et al.. (2005). A Prospective Study of Meat and Meat Mutagens and Prostate Cancer Risk. Cancer Research. 65(24). 11779–11784. 143 indexed citations
12.
Blanchard, Chris M., Frank Baker, Maxine M. Denniston, et al.. (2003). Is absolute amount or change in exercise more associated with quality of life in adult cancer survivors?. Preventive Medicine. 37(5). 389–395. 37 indexed citations
13.
Blanchard, Chris M., Maxine M. Denniston, Frank Baker, et al.. (2003). Do Adults Change Their Lifestyle Behaviors After a Cancer Diagnosis?. American Journal of Health Behavior. 27(3). 246–256. 210 indexed citations
14.
Hann, Danette, Frank Baker, Maxine M. Denniston, et al.. (2002). The influence of social support on depressive symptoms in cancer patients. Journal of Psychosomatic Research. 52(5). 279–283. 123 indexed citations
15.
Gelmann, Edward P., David Chia, Paul F. Pinsky, et al.. (2001). Relationship of demographic and clinical factors to free and total prostate-specific antigen. Urology. 58(4). 561–566. 22 indexed citations
16.
Subar, Amy F., Regina G. Ziegler, Frances E. Thompson, et al.. (2001). Is Shorter Always Better? Relative Importance of Questionnaire Length and Cognitive Ease on Response Rates and Data Quality for Two Dietary Questionnaires. American Journal of Epidemiology. 153(4). 404–409. 133 indexed citations
17.
Hayes, Richard B., Douglas Reding, William Kopp, et al.. (2000). Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Controlled Clinical Trials. 21(6). 349S–355S. 114 indexed citations
18.
Witt, Patricia L., Paul S. Ritch, Douglas Reding, et al.. (1993). Phase I trial of an oral immunomodulator and interferon inducer in cancer patients.. PubMed. 53(21). 5176–80. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalina Jorge Koifman Breakdown of academic impact, for papers by Isaac J. Ergas Breakdown of academic impact, for papers by Maria Jackson Breakdown of academic impact, for papers by Deborah A. Boggs Breakdown of academic impact, for papers by C Hermon Breakdown of academic impact, for papers by Noritoshi Tanida Breakdown of academic impact, for papers by Chong Teh Breakdown of academic impact, for papers by T. Greg Hislop Breakdown of academic impact, for papers by Sameer M. Siddiqi Breakdown of academic impact, for papers by J R Daling
Rankless by CCL
2026